Finance

Beta
Lists
EP3:FRA
OraSure Technologies Inc
€3.38
+0.60%
(+0.020) 1D
Jun 4, 8:10:03 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EP3...
Open
€3.38
High
€3.38
Low
€3.38
Mkt. cap
271.95M
Avg. vol.
202.00
Volume
0.00
52-wk high
€3.76
52-wk low
€1.80
No. of employees
500
Open
€3.38
High
€3.38
Low
€3.38
Mkt. cap
271.95M
Avg. vol.
202.00
Volume
0.00
52-wk high
€3.76
52-wk low
€1.80
No. of employees
500
News stories
From sources across the web
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees500
FoundedDec 11, 1987
HeadquartersBethlehem, Pennsylvania, United States
SectorMedical device
Websiteorasure.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
31.24M
27.08M
26.76M
27.92M
Cost of goods sold
18.08M
15.31M
15.80M
16.06M
Cost of revenue
18.08M
15.31M
15.80M
16.06M
Research and development expenses
11.40M
10.11M
11.42M
13.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.05M
17.38M
15.90M
20.39M
Operating expense
30.45M
27.49M
27.32M
33.78M
Total operating expenses
48.54M
42.80M
43.12M
49.83M
Operating income
-17.29M
-15.71M
-16.35M
-21.91M
Other non operating income
-38.00K
2.20M
1.87M
128.00K
EBT including unusual items
-17.69M
-13.66M
-19.08M
-22.81M
EBT excluding unusual items
-16.96M
-13.29M
-15.32M
-21.45M
Income tax expense
2.00M
47.00K
210.00K
-432.00K
Effective tax rate
-11.30%
-0.34%
-1.10%
1.89%
Other operating expenses
-
-
-
-
Net income
-19.69M
-13.71M
-19.29M
-22.38M
Net profit margin
-63.03%
-50.63%
-72.06%
-80.13%
Earnings per share
-0.19
-0.13
-0.19
-0.24
Interest and investment income
2.07M
-
-
1.22M
Interest expense
-
-
-
-
Net interest expenses
2.07M
-
-
1.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.77M
-13.26M
-13.95M
-19.57M
Gain or loss from assets sale
-
-213.00K
268.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer